Tekla Capital Management as of Dec. 31, 2019
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 214 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amgen (AMGN) | 5.6 | $149M | 617k | 241.07 | |
Johnson & Johnson (JNJ) | 5.1 | $134M | 917k | 145.87 | |
Gilead Sciences (GILD) | 4.7 | $123M | 1.9M | 64.98 | |
Merck & Co (MRK) | 4.2 | $110M | 1.2M | 90.95 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.1 | $108M | 494k | 218.95 | |
Illumina (ILMN) | 3.4 | $90M | 273k | 331.74 | |
Biogen Idec (BIIB) | 3.2 | $85M | 285k | 296.73 | |
Pfizer (PFE) | 3.1 | $82M | 2.1M | 39.18 | |
Regeneron Pharmaceuticals (REGN) | 2.9 | $76M | 201k | 375.48 | |
UnitedHealth (UNH) | 2.8 | $73M | 249k | 293.98 | |
Medtronic (MDT) | 2.0 | $53M | 471k | 113.45 | |
Bristol Myers Squibb (BMY) | 1.9 | $50M | 775k | 64.19 | |
Alexion Pharmaceuticals | 1.8 | $47M | 436k | 108.15 | |
Abbott Laboratories (ABT) | 1.6 | $41M | 472k | 86.86 | |
Thermo Fisher Scientific (TMO) | 1.5 | $40M | 123k | 324.87 | |
Cigna Corp (CI) | 1.5 | $39M | 191k | 204.49 | |
CVS Caremark Corporation (CVS) | 1.4 | $37M | 498k | 74.29 | |
Incyte Corporation (INCY) | 1.3 | $34M | 383k | 87.32 | |
Seattle Genetics | 1.2 | $32M | 277k | 114.26 | |
Anthem (ELV) | 1.2 | $31M | 102k | 302.03 | |
Allergan | 1.1 | $31M | 160k | 191.17 | |
Abbvie (ABBV) | 1.1 | $30M | 341k | 88.54 | |
Eli Lilly & Co. (LLY) | 1.0 | $28M | 210k | 131.43 | |
Boston Scientific Corporation (BSX) | 1.0 | $26M | 564k | 45.22 | |
Danaher Corporation (DHR) | 1.0 | $25M | 166k | 153.48 | |
Zoetis Inc Cl A (ZTS) | 0.9 | $25M | 190k | 132.35 | |
Stryker Corporation (SYK) | 0.9 | $24M | 114k | 209.94 | |
Sarepta Therapeutics (SRPT) | 0.9 | $23M | 182k | 129.04 | |
BioMarin Pharmaceutical (BMRN) | 0.9 | $23M | 277k | 84.55 | |
Intuitive Surgical (ISRG) | 0.9 | $23M | 39k | 591.14 | |
Mylan Nv | 0.8 | $21M | 1.0M | 20.10 | |
Neurocrine Biosciences (NBIX) | 0.8 | $21M | 193k | 107.49 | |
Novartis (NVS) | 0.8 | $20M | 211k | 94.69 | |
Humana (HUM) | 0.8 | $20M | 55k | 366.51 | |
Becton, Dickinson and (BDX) | 0.7 | $18M | 66k | 271.97 | |
Pra Health Sciences | 0.6 | $17M | 153k | 111.15 | |
Alnylam Pharmaceuticals (ALNY) | 0.6 | $17M | 144k | 115.17 | |
Edwards Lifesciences (EW) | 0.6 | $16M | 70k | 233.29 | |
Welltower Inc Com reit (WELL) | 0.6 | $16M | 192k | 81.78 | |
Hca Holdings (HCA) | 0.5 | $14M | 96k | 147.81 | |
AstraZeneca (AZN) | 0.5 | $14M | 276k | 49.86 | |
Beigene | 0.5 | $13M | 81k | 165.76 | |
Novo Nordisk A/S (NVO) | 0.5 | $13M | 221k | 57.88 | |
Jazz Pharmaceuticals (JAZZ) | 0.5 | $13M | 86k | 149.28 | |
Esperion Therapeutics (ESPR) | 0.5 | $13M | 214k | 59.63 | |
Ionis Pharmaceuticals (IONS) | 0.5 | $13M | 210k | 60.41 | |
GlaxoSmithKline | 0.5 | $12M | 257k | 46.99 | |
Omega Healthcare Investors (OHI) | 0.5 | $12M | 285k | 42.35 | |
Milestone Pharmaceuticals (MIST) | 0.5 | $12M | 747k | 16.01 | |
Global Blood Therapeutics In | 0.4 | $12M | 147k | 79.49 | |
IDEXX Laboratories (IDXX) | 0.4 | $11M | 44k | 261.13 | |
Ventas (VTR) | 0.4 | $11M | 191k | 57.74 | |
Bio-techne Corporation (TECH) | 0.4 | $11M | 50k | 219.50 | |
Horizon Therapeutics | 0.4 | $11M | 305k | 36.20 | |
Baxter International (BAX) | 0.4 | $11M | 130k | 83.62 | |
Medicines Company | 0.4 | $10M | 121k | 84.94 | |
Immunomedics | 0.4 | $10M | 487k | 21.16 | |
Agios Pharmaceuticals (AGIO) | 0.4 | $10M | 216k | 47.75 | |
Sabra Health Care REIT (SBRA) | 0.4 | $9.9M | 466k | 21.34 | |
AmerisourceBergen (COR) | 0.4 | $9.8M | 116k | 85.02 | |
Zimmer Holdings (ZBH) | 0.4 | $9.5M | 64k | 149.68 | |
Centene Corporation (CNC) | 0.4 | $9.4M | 150k | 62.87 | |
Ascendis Pharma A S (ASND) | 0.4 | $9.6M | 69k | 139.11 | |
McKesson Corporation (MCK) | 0.3 | $9.3M | 67k | 138.31 | |
Sanofi-Aventis SA (SNY) | 0.3 | $9.4M | 187k | 50.20 | |
ACADIA Pharmaceuticals (ACAD) | 0.3 | $9.3M | 218k | 42.78 | |
Mirati Therapeutics | 0.3 | $9.1M | 71k | 128.86 | |
Blueprint Medicines (BPMC) | 0.3 | $9.4M | 117k | 80.11 | |
Exelixis (EXEL) | 0.3 | $9.1M | 515k | 17.62 | |
Novocure Ltd ord (NVCR) | 0.3 | $9.1M | 107k | 84.27 | |
Amarin Corporation (AMRN) | 0.3 | $8.8M | 408k | 21.44 | |
Epizyme | 0.3 | $8.7M | 353k | 24.60 | |
Physicians Realty Trust | 0.3 | $8.7M | 457k | 18.94 | |
Bluebird Bio (BLUE) | 0.3 | $8.4M | 96k | 87.75 | |
Fibrogen (FGEN) | 0.3 | $8.3M | 194k | 42.89 | |
Atreca Inc Cl A (BCEL) | 0.3 | $8.1M | 525k | 15.47 | |
Medical Properties Trust (MPW) | 0.3 | $7.9M | 374k | 21.11 | |
Teva Pharmaceutical Industries (TEVA) | 0.3 | $7.7M | 786k | 9.80 | |
LTC Properties (LTC) | 0.3 | $7.4M | 166k | 44.77 | |
Argenx Se (ARGX) | 0.3 | $7.2M | 45k | 160.53 | |
Sutro Biopharma (STRO) | 0.3 | $7.1M | 641k | 11.00 | |
Sage Therapeutics (SAGE) | 0.3 | $6.9M | 96k | 72.19 | |
Dentsply Sirona (XRAY) | 0.3 | $6.8M | 120k | 56.59 | |
Syneos Health | 0.3 | $6.9M | 116k | 59.48 | |
Allakos (ALLK) | 0.3 | $6.8M | 71k | 95.36 | |
Arrowhead Pharmaceuticals (ARWR) | 0.2 | $6.7M | 105k | 63.43 | |
Iovance Biotherapeutics (IOVA) | 0.2 | $6.7M | 244k | 27.68 | |
Align Technology (ALGN) | 0.2 | $6.2M | 22k | 279.02 | |
SPDR S&P Biotech (XBI) | 0.2 | $6.5M | 68k | 95.11 | |
Nektar Therapeutics (NKTR) | 0.2 | $6.1M | 284k | 21.58 | |
Flamel Technologies Sa | 0.2 | $6.2M | 815k | 7.55 | |
Teleflex Incorporated (TFX) | 0.2 | $5.9M | 16k | 376.41 | |
Health Care SPDR (XLV) | 0.2 | $5.5M | 54k | 101.85 | |
Abiomed | 0.2 | $5.6M | 33k | 170.59 | |
Zogenix | 0.2 | $5.6M | 108k | 52.13 | |
Iqvia Holdings (IQV) | 0.2 | $5.5M | 36k | 154.52 | |
Galera Therapeutics (GRTX) | 0.2 | $5.5M | 417k | 13.16 | |
Laboratory Corp. of America Holdings | 0.2 | $5.3M | 31k | 169.17 | |
Gw Pharmaceuticals Plc ads | 0.2 | $5.2M | 50k | 104.57 | |
Pieris Pharmaceuticals | 0.2 | $5.2M | 1.4M | 3.62 | |
Reata Pharmaceuticals Inc Cl A | 0.2 | $5.4M | 26k | 204.41 | |
Xencor (XNCR) | 0.2 | $5.1M | 148k | 34.39 | |
Uniqure Nv (QURE) | 0.2 | $5.1M | 71k | 71.67 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.2 | $4.7M | 39k | 120.51 | |
United Therapeutics Corporation (UTHR) | 0.2 | $4.8M | 54k | 88.09 | |
Smith & Nephew (SNN) | 0.2 | $4.8M | 100k | 48.07 | |
Ptc Therapeutics I (PTCT) | 0.2 | $4.8M | 99k | 48.03 | |
Crispr Therapeutics (CRSP) | 0.2 | $4.6M | 76k | 60.90 | |
Rocket Pharmaceuticals (RCKT) | 0.2 | $4.7M | 208k | 22.76 | |
ArQule | 0.2 | $4.4M | 220k | 19.96 | |
Acadia Healthcare (ACHC) | 0.2 | $4.5M | 136k | 33.22 | |
Acceleron Pharma | 0.2 | $4.6M | 86k | 53.02 | |
Ardelyx (ARDX) | 0.2 | $4.6M | 608k | 7.51 | |
Editas Medicine (EDIT) | 0.2 | $4.4M | 148k | 29.61 | |
Peak (DOC) | 0.2 | $4.4M | 129k | 34.47 | |
Rts/bristol-myers Squibb Compa | 0.2 | $4.4M | 1.5M | 3.01 | |
ResMed (RMD) | 0.2 | $4.3M | 28k | 154.96 | |
Ligand Pharmaceuticals In (LGND) | 0.2 | $4.3M | 41k | 104.29 | |
Takeda Pharmaceutical (TAK) | 0.2 | $4.1M | 210k | 19.73 | |
Tenet Healthcare Corporation (THC) | 0.2 | $4.3M | 113k | 38.03 | |
Intercept Pharmaceuticals In | 0.2 | $4.3M | 34k | 123.93 | |
Ultragenyx Pharmaceutical (RARE) | 0.2 | $4.2M | 98k | 42.71 | |
Bausch Health Companies (BHC) | 0.2 | $4.2M | 139k | 29.92 | |
Insmed (INSM) | 0.1 | $3.9M | 165k | 23.88 | |
Alkermes (ALKS) | 0.1 | $4.0M | 198k | 20.40 | |
Portola Pharmaceuticals | 0.1 | $3.9M | 162k | 23.88 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $4.0M | 131k | 30.62 | |
Amicus Therapeutics (FOLD) | 0.1 | $3.6M | 369k | 9.74 | |
Deciphera Pharmaceuticals | 0.1 | $3.8M | 61k | 62.25 | |
Mettler-Toledo International (MTD) | 0.1 | $3.3M | 4.2k | 793.27 | |
Masimo Corporation (MASI) | 0.1 | $3.4M | 22k | 158.04 | |
Inogen (INGN) | 0.1 | $3.5M | 51k | 68.34 | |
Charles River Laboratories (CRL) | 0.1 | $3.2M | 21k | 152.76 | |
Fate Therapeutics (FATE) | 0.1 | $3.2M | 166k | 19.57 | |
Intra Cellular Therapies (ITCI) | 0.1 | $3.2M | 94k | 34.31 | |
Theravance Biopharma (TBPH) | 0.1 | $3.0M | 118k | 25.89 | |
Alcon (ALC) | 0.1 | $3.1M | 55k | 56.57 | |
Healthcare Realty Trust Incorporated | 0.1 | $2.8M | 84k | 33.37 | |
Diversified Healthcare Trust (DHC) | 0.1 | $3.0M | 358k | 8.44 | |
Pacific Biosciences of California (PACB) | 0.1 | $2.5M | 496k | 5.14 | |
Ra Pharmaceuticals | 0.1 | $2.6M | 56k | 46.93 | |
Agilent Technologies Inc C ommon (A) | 0.1 | $2.3M | 27k | 85.31 | |
Endo International | 0.1 | $2.5M | 532k | 4.69 | |
Quotient | 0.1 | $2.5M | 260k | 9.51 | |
Healthequity (HQY) | 0.1 | $2.4M | 32k | 74.06 | |
Coherus Biosciences (CHRS) | 0.1 | $2.3M | 125k | 18.00 | |
Steris Plc Ord equities (STE) | 0.1 | $2.3M | 15k | 152.40 | |
Hologic (HOLX) | 0.1 | $2.2M | 43k | 52.20 | |
Koninklijke Philips Electronics NV (PHG) | 0.1 | $2.1M | 43k | 48.81 | |
Quest Diagnostics Incorporated (DGX) | 0.1 | $2.2M | 21k | 106.78 | |
Evolent Health (EVH) | 0.1 | $2.1M | 231k | 9.05 | |
Allogene Therapeutics (ALLO) | 0.1 | $2.1M | 80k | 25.98 | |
PerkinElmer (RVTY) | 0.1 | $1.8M | 19k | 97.10 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $1.8M | 91k | 20.26 | |
Cellectis S A (CLLS) | 0.1 | $1.9M | 110k | 17.12 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $1.9M | 118k | 16.25 | |
Aerie Pharmaceuticals | 0.1 | $1.6M | 67k | 24.17 | |
Global Medical Reit (GMRE) | 0.1 | $1.6M | 118k | 13.23 | |
Medpace Hldgs (MEDP) | 0.1 | $1.6M | 19k | 84.04 | |
Ac Immune Sa (ACIU) | 0.1 | $1.5M | 172k | 8.52 | |
Biohaven Pharmaceutical Holding | 0.1 | $1.6M | 29k | 54.45 | |
Verona Pharma Plc ads (VRNA) | 0.1 | $1.6M | 275k | 5.75 | |
Ovid Therapeutics (OVID) | 0.1 | $1.5M | 373k | 4.15 | |
Zai Lab (ZLAB) | 0.1 | $1.6M | 38k | 41.60 | |
Avrobio Ord (AVRO) | 0.1 | $1.5M | 75k | 20.13 | |
Sangamo Biosciences (SGMO) | 0.1 | $1.3M | 150k | 8.37 | |
Heron Therapeutics (HRTX) | 0.1 | $1.4M | 60k | 23.50 | |
Revance Therapeutics (RVNC) | 0.1 | $1.4M | 86k | 16.23 | |
New Senior Inv Grp | 0.1 | $1.2M | 158k | 7.65 | |
Healthcare Tr Amer Inc cl a | 0.1 | $1.4M | 46k | 30.28 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $1.3M | 97k | 13.11 | |
Dermira | 0.1 | $1.4M | 89k | 15.16 | |
Galapagos Nv- (GLPG) | 0.1 | $1.4M | 6.5k | 206.79 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $1.5M | 36k | 40.96 | |
Myokardia | 0.1 | $1.4M | 19k | 72.90 | |
Madrigal Pharmaceuticals (MDGL) | 0.1 | $1.2M | 13k | 91.08 | |
Arena Pharmaceuticals | 0.1 | $1.3M | 28k | 45.43 | |
Bridgebio Pharma (BBIO) | 0.1 | $1.4M | 39k | 35.05 | |
Foamix Pharmaceuticals | 0.0 | $1.0M | 301k | 3.33 | |
Eidos Therapeutics | 0.0 | $1.1M | 20k | 57.40 | |
Universal Health Realty Income Trust (UHT) | 0.0 | $674k | 5.7k | 117.38 | |
ImmunoGen | 0.0 | $860k | 168k | 5.11 | |
Wave Life Sciences (WVE) | 0.0 | $802k | 100k | 8.02 | |
Intellia Therapeutics (NTLA) | 0.0 | $808k | 55k | 14.68 | |
Zymeworks | 0.0 | $691k | 15k | 45.48 | |
Morphosys (MOR) | 0.0 | $692k | 19k | 35.69 | |
Axonics Modulation Technolog (AXNX) | 0.0 | $779k | 28k | 27.72 | |
Community Health Systems (CYH) | 0.0 | $591k | 204k | 2.90 | |
Myriad Genetics (MYGN) | 0.0 | $512k | 19k | 27.23 | |
Spectrum Pharmaceuticals | 0.0 | $417k | 115k | 3.64 | |
Puma Biotechnology (PBYI) | 0.0 | $624k | 71k | 8.75 | |
Perrigo Company (PRGO) | 0.0 | $559k | 11k | 51.67 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $460k | 446k | 1.03 | |
Community Healthcare Tr (CHCT) | 0.0 | $639k | 15k | 42.89 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $610k | 159k | 3.84 | |
Clearside Biomedical (CLSD) | 0.0 | $480k | 165k | 2.90 | |
Molecular Templates | 0.0 | $592k | 42k | 13.99 | |
Rubius Therapeutics | 0.0 | $650k | 68k | 9.51 | |
Genmab A/s -sp (GMAB) | 0.0 | $369k | 17k | 22.34 | |
Cymabay Therapeutics | 0.0 | $173k | 88k | 1.96 | |
Merus N V (MRUS) | 0.0 | $299k | 21k | 14.09 | |
Aerpio Pharmaceuticals | 0.0 | $162k | 258k | 0.63 | |
Magenta Therapeutics | 0.0 | $254k | 17k | 15.16 | |
Y Mabs Therapeutics (YMAB) | 0.0 | $354k | 11k | 31.26 | |
Guardant Health (GH) | 0.0 | $339k | 4.3k | 78.24 | |
Turning Point Therapeutics I | 0.0 | $354k | 5.7k | 62.36 | |
Arca Biopharma (ABIO) | 0.0 | $206k | 36k | 5.71 | |
Mallinckrodt Pub | 0.0 | $115k | 33k | 3.49 | |
Bellicum Pharma | 0.0 | $77k | 60k | 1.28 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $92k | 77k | 1.19 | |
Quorum Health | 0.0 | $23k | 24k | 0.97 | |
Celldex Therapeutics (CLDX) | 0.0 | $16k | 7.1k | 2.27 | |
Novavax (NVAX) | 0.0 | $114k | 29k | 3.99 | |
Tetraphase Pharms | 0.0 | $121k | 43k | 2.82 |